Dublin-based Medtronic has announced the commercial launch of the IN.PACT Admiral Drug-Coated Balloon (DCB) in Japan. I...
Japan based Kaneka Corporation has installed continuous manufacturing equipment to be applied to pharmaceutical products...
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...
Researchers at Okayama University developed a supporting device for accurately placing hemodialysis catheters on kidney ...
Takeda has entered into a $100 million partnership with newly-launched biotech Ambys Medicines to support its discovery ...
Qiagen N.V. has announced a collaboration with SRL, Inc., the largest clinical testing laboratory company in Japan, to p...
Eisai Co., Ltd. announced that it has entered into an agreement to grant exclusive development and marketing rights for ...
Eisai Co., Ltd. and Merck & Co., Inc. announced that the U.S. Food and Drug Administration (FDA) granted Break...
A team of researchers from Kyoto University, Japan has announced the world's first human trial using a kind of stem cell...
SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, has announced that it has been aw...
Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the European Medicines Agency's Committee for Med...
Japan's Solasia Pharma, a specialty pharmaceutical company based in Asia, has officially announced that Sancuso (Granise...
Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigati...
Terumo Corporation recently announced that it has entered into an agreement to acquire Essen Technology (Beijing) Co., L...
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via...
Researchers at Riken and the National Cancer Centre in Japan have succeeded in using artificial intelligence (AI) to ide...
Sato Pharmaceutical obtained marketing and manufacturing approval for NAILIN® Capsules 100mg as an oral treatment fo...
Eisai Co., Ltd. announces that a total of 13 presentations highlighting results from a Phase II clinical study (Study 20...
